ALK is a research-driven, global pharmaceutical company focusing on allergy prevention, diagnosis and treatment. We are the foremost innovators in allergy immunotherapy _ a unique treatment which reduces allergic symptoms and treats the cause of the allergy.
Founded in 1923, ALK has devoted decades of research and development to improve quality of life for the many allergy sufferers whose disease remains uncontrolled despite the use of symptom-relieving medication, by developing products that provide long-lasting relief.
ALK offers allergy immunotherapy products in the form of injections, sublingual drops and sublingual tablets _ the latter is the newest, most documented and most convenient form of treatment. In addition, ALK also produces an adrenaline auto-injector for the treatment of severe allergic reactions (anaphylaxis) and also manufactures products used in the diagnosis of allergies.
The company has approximately 2,000 employees, with subsidiaries, production facilities and distributors worldwide. ALK is headquartered in Denmark and listed on NASDAQ Copenhagen (OMX: ALK B).
Read more about ALK at www.alk.net
- Company Name:Alk Abell_
(View Trends)
-
Headquarters: (View Map)Hoersholm, Denmark
-
Pharmaceuticals
-
1,000 - 5,000 employees
- 1334897 Global Rank
- 1818412 United States
-
Search74.88%
-
Direct21.70%
-
Social1.86%
-
Referrals1.10%
-
Mail0.46%
-
Display0.00%
![](https://d2msby6dr6c92m.cloudfront.net/assets/similar-web-d795926c93666fae2318ea9a54f39ba58f506fd2065875b501c4f2682992c700.png)
- 10 SDKs
![](https://is1-ssl.mzstatic.com/image/thumb/Purple125/v4/6a/cc/ee/6accee2e-61de-6921-1544-f956dff60eb2/source/100x100bb.jpg)
- App Url: https://itunes.apple.com/app/alk-abello-3/id970396792
- App Support: http://www.alk.net/es
- Genre: Medical
- Bundle ID: com.pairroxz.jextspanish
- App Size: 15.4 M
- Version: 1.0
- Release Date: March 12th, 2015
- Update Date: March 12th, 2015
Description:
La anafilaxia es una reacción alérgica grave de instauración rápida y potencialmente mortal. Por todo ello, requiere un tratamiento inmediato. En muchas ocasiones es el mismo paciente quién debe administrarse una dosis de adrenalina que le permita superar la crisis anafiláctica.
Esta aplicación permite a los pacientes afectados por la anafilaxia familiarizarse con su enfermedad y con el manejo de su autoinyector de adrenalina. También incorpora herramientas que facilitan al paciente concienciar a su entorno sobre las reacciones alérgicas más graves.
![](https://is5-ssl.mzstatic.com/image/thumb/Purple3/v4/8a/9a/bf/8a9abf53-a5f3-8258-83c0-fbd89ee7373e/pr_source.jpg/696x696bb.jpg)
![](https://is2-ssl.mzstatic.com/image/thumb/Purple5/v4/d9/37/73/d9377365-8e50-9f96-c939-82ff40d81bd7/pr_source.jpg/696x696bb.jpg)
![](https://is4-ssl.mzstatic.com/image/thumb/Purple3/v4/61/ee/44/61ee444c-fdb0-2ebe-aa75-7caba227aef2/pr_source.jpg/696x696bb.jpg)
![](https://is1-ssl.mzstatic.com/image/thumb/Purple3/v4/67/74/a3/6774a373-b763-0685-a373-c82db3e9bda6/pr_source.jpg/696x696bb.jpg)
![](https://is5-ssl.mzstatic.com/image/thumb/Purple1/v4/f7/a8/1f/f7a81fe7-583c-f02d-45d5-12f90d7e2df9/pr_source.jpg/696x696bb.jpg)
![](https://d2msby6dr6c92m.cloudfront.net/assets/empty-logo-fc156a9d90ffff7cdddf58638bd9c167a08217ff8677724b3fcbdee9290a4d30.png)
![](https://d2msby6dr6c92m.cloudfront.net/assets/empty-logo-fc156a9d90ffff7cdddf58638bd9c167a08217ff8677724b3fcbdee9290a4d30.png)
![](https://d2msby6dr6c92m.cloudfront.net/assets/empty-logo-fc156a9d90ffff7cdddf58638bd9c167a08217ff8677724b3fcbdee9290a4d30.png)
![](https://d2msby6dr6c92m.cloudfront.net/assets/empty-logo-fc156a9d90ffff7cdddf58638bd9c167a08217ff8677724b3fcbdee9290a4d30.png)
![](https://d2msby6dr6c92m.cloudfront.net/assets/empty-logo-fc156a9d90ffff7cdddf58638bd9c167a08217ff8677724b3fcbdee9290a4d30.png)
![](https://d2msby6dr6c92m.cloudfront.net/assets/empty-logo-fc156a9d90ffff7cdddf58638bd9c167a08217ff8677724b3fcbdee9290a4d30.png)
![](https://d2msby6dr6c92m.cloudfront.net/assets/empty-logo-fc156a9d90ffff7cdddf58638bd9c167a08217ff8677724b3fcbdee9290a4d30.png)
![](https://d2msby6dr6c92m.cloudfront.net/assets/empty-logo-fc156a9d90ffff7cdddf58638bd9c167a08217ff8677724b3fcbdee9290a4d30.png)
![](https://d2msby6dr6c92m.cloudfront.net/assets/empty-logo-fc156a9d90ffff7cdddf58638bd9c167a08217ff8677724b3fcbdee9290a4d30.png)
![](https://d2msby6dr6c92m.cloudfront.net/assets/empty-logo-fc156a9d90ffff7cdddf58638bd9c167a08217ff8677724b3fcbdee9290a4d30.png)
-
Standard0%
![](http://adimages.adbeat.com/c16fd821bdd1e13ebbc45189e49b59cb.jpg)
![](http://adimages.adbeat.com/c16fd821bdd1e13ebbc45189e49b59cb.jpg)
They are headquartered at Hoersholm, Denmark, and have 2 advertising & marketing contacts listed on Kochava. Alk Abell_ works with Advertising technology companies such as DoubleClick.Net, AppNexus, Adform, Eyeota, eXelate, Beeswax, Affectv, Avocet, LinkedIn Ads, DemDex, FLoC, comScore Activation, Atlas, FLoC Opt-Out.